http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2015102537-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C335-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4995 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-499 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate | 2013-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2015102537-A |
| titleOfInvention | CYANOGUANIDINES AND THEIR APPLICATION AS ANTIVIRAL AGENTS |
| abstract | 1. The compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein Ar is phenyl or monocyclic heteroaryl having a structure that corresponds to a formula selected from the group consisting of: wherein R is selected from the group consisting of hydrogen; amino; hydroxyl; cyano; halogen; C 1-6 alkyl; C-alkenyl; C-alkynyl; C-alkoxy; haloalkyl; haloalkoxy; oxoalkyl; alkylamino; dialkylamino; alkoxyalkyl; aminoalkyl; N-alkylaminoalkyl; N, N-dialkylaminoalkyl; -L-C (O) -OR or -L-S (O) R, where L is a bond or alkylene, and R 'is hydrogen, C-C1-6 alkyl or hydroxyalkyl; -L-O-C (O) -R, where L is a bond or alkylene, and R is C-C1-6 alkyl or hydroxyalkyl; -L-C (O) -NRR, where L is a bond or alkylene, and each R and R are independently selected from the group consisting of hydrogen, alkyl and hydroxyalkyl; -L-NR-C (O) -R, wherein L is a bond or alkylene, R is hydrogen or alkyl, and R is alkyl or hydroxyalkyl; sulfamoyl; N- (alkyl) sulfamoyl; N, N- (dialkyl) sulfamoyl; sulfonamide; alkylthio; and thioalkyl; each R, R, R, and R is independently selected from the group consisting of hydrogen, cyano, halogen, C-C1-6 alkyl, alkoxy, amino, alkylamino, dialkylamino, cycloalkyl, heterocyclyl, haloalkoxy and haloalkyl; or R and R, or R and R, or R and R taken together are —O — CH — O—; X, X, X, X and X are CR, CR, CR, CR and CR, respectively, or N; where 1, 2 or 3 X, X, X, X, and X are N; where R is selected from the group consisting of hydrogen; amino; hydroxyl; cyano; halogen; C 1-6 alkyl; C-alkenyl; C-alkynyl; haloalkyl; haloalkoxy; oxoalkyl; alkoxy; alkylamino; dialkylamino; alkoxyalkyl; aminoalkyl; N-alkylaminoalkyl; N, N-dialkylaminoalkyl; -L-C (O) -OR or -L-S (O) R, where L is a bond or alkylene, and R is |
| priorityDate | 2012-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.